Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |